{"product_id":"china-biomanufacturing-comparative-analysis","title":"China Biomanufacturing Comparative Analysis","description":"\u003cp\u003eChina Biomanufacturing Comparative Analysis\u003cbr\u003e\n2nd Annual China’s Position in Global Manufacturing: A Comparison of China’s Emerging Position vs Established Regions’ Manufacturing Capacity and Production.\u003c\/p\u003e\n\n\u003cp\u003eAn in-depth review of emerging trends and opportunities, with comparative data from BioPlan’s 20th Annual Report and Survey of Biopharmaceutical Manufacturing.\u003c\/p\u003e\n\n\u003cp\u003eThis analysis will help decision makers understand the changing China biopharmaceutical industry to make strategic decisions on why and when they should enter the China market.\u003c\/p\u003e\n\n\u003cp\u003eBy the Numbers\u003c\/p\u003e\n\n\u003cp\u003eIn-depth review and analysis of China biomanufacturing vs US, Western Europe and Rest of World (ROW)\u003cbr\u003e\n56 pages\u003cbr\u003e\nOver 20 Figures and Tables\u003c\/p\u003e\n\n\u003cp\u003eHighlights and Table of Contents – In this analysis, we cover the following areas, based on data from the BioPlan 20th Annual Report:\u003c\/p\u003e\n\n\u003cp\u003eSingle Biomanufacturing Trend of 2023: What is the SINGLE most important biomanufacturing trend\/operational area the industry must focus efforts on in 2023?\u003c\/p\u003e\n\n\u003cp\u003eNovel Bioprocessing System To Test: Which novel bioprocessing systems or innovations do you plan to evaluate or test within your facility\/company in the next 12 months? [Select all that apply]\u003c\/p\u003e\n\n\u003cp\u003eAverage Cost For Recombinant Protein: What is your AVERAGE cost per gram for your Facility’s PRIMARY Recombinant Protein manufactured at your facility ($USD)? (For Protein\/mAb, not finished product)\u003c\/p\u003e\n\n\u003cp\u003eTiter Range: Approximately, what range of titers are you currently obtaining for each of the following?\u003c\/p\u003e\n\n\u003cp\u003eCurrent Percent of Total Capacity for Facility Operation, by Production System: Consider your facility’s total capacity, and the current “percent of capacity”.\u003c\/p\u003e\n\n\u003cp\u003eCapacity Constraints: To what extent do you believe your facility is experiencing production capacity constraints today?\u003c\/p\u003e\n\n\u003cp\u003eDownstream Bioprocessing Steps Creating Overall Capacity Constraints: Describe the extent to which your purification\/chromatography steps create OVERALL capacity constraints at your facility?\u003c\/p\u003e\n\n\u003cp\u003eImportant Areas to Address for Industry to Avoid Significant Capacity Constraints: If this industry is to avoid significant capacity constraints, the most important areas to be addressed today are?\u003c\/p\u003e\n\n\u003cp\u003eBudget and Funding Percentage Changes Over the Next 12 Months: By about what percent do you believe your BUDGET and FUNDING will change for each of the following over the next 12 months?\u003c\/p\u003e\n\n\u003cp\u003eActions to Reduce Overall Bioprocessing Costs During the Past 12 Months: During the past 12 months, which actions has your facility undertaken to reduce overall costs?\u003c\/p\u003e\n\n\u003cp\u003eSingle-use\/disposable Biomanufacturing Systems: About what percent of your biomanufacturing systems (e.g., # of major components\/devices) would you describe as ‘single-use’ or disposable?\u003c\/p\u003e\n\n\u003cp\u003eChange in Spending on OUTSOURCING for R\u0026amp;D or Manufacturing in the Next 12 Months: How will your spending on OUTSOURCING of R\u0026amp;D or manufacturing change in the next 12 months?\u003c\/p\u003e\n\n\u003cp\u003eOutsourcing Activities: How much outsourcing of the following activities is done by your facility today?\u003c\/p\u003e\n\n\u003cp\u003eTop 3 New Bioprocessing Expenditures For Suppliers: In which new areas were your facility’s top 3 NEW bioprocessing expenditures in the past year?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 56 Pages \/ MCW16230291","offer_id":47647063933234,"sku":null,"price":2940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/china-biomanufacturing-comparative-analysis","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}